Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session

Gainers

• My Size, Inc. MYSZ shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.
• Pharvaris N.V. PHVS shares climbed 56.7% to $4.0914 after the company reported top-line Phase 2 data from the RAPIDe-1 study of PHVS416 for the on-demand treatment of HAE attacks. The primary endpoint and all secondary endpoints were met.
• Nymox Pharmaceutical Corporation NYMX gained 39.3% to $0.69. NYMOX recently announced new marketing submission for NYMOZARFEX for benign prostatic hyperplasia.
• Express, Inc. EXPR gained 39% to $1.7807 after the company and WHP Global announced they have entered into a mutually transformative strategic partnership. WHP to invest $25 million to acquire 5.4 million newly issued shares of EXPR at $4.60 per share. Express reported a third-quarter FY22 sales decline of 8% year-on-year to $434.1 million
• Rent the Runway, Inc. RENT shares rose 36.8% to $1.8609 after the company reported better-than-expected Q3 sales results. The company also raised its FY22 sales guidance above estimates.
• Hello Group Inc. MOMO jumped 34.7% to $7.07 after the company reported better-than-expected Q3 results.
• Power REIT PW gained 34.7% to $5.59.
• Gelesis Holdings, Inc. GLS gained 25.8% to $0.4061.
• BioVie Inc. BIVI rose 23% to $7.25.
• ZW Data Action Technologies Inc. CNET jumped 21.6% to $0.7850. ZW Data Action Tech, last month, posted a Q3 loss of $0.08 per share.
• Agora, Inc. API gained 19.9% to $3.7050.
• Cardlytics, Inc. CDLX rose 19.5% to $4.97.
• Carvana Co. CVNA jumped 19% to $4.5650. Recent reports indicated that some of the company's largest creditors have signed a pact to prevent a potential creditor fight.
• Entrada Therapeutics, Inc. TRDA rose 18.5% to $21.00 after the company and Vertex Pharmaceuticals announced a collaboration to discover and develop Endosomal Escape Vehicle therapeutics for myotonic dystrophy type 1.
• Zhihu Inc. ZH gained 18% to $1.5385.
• Ciena Corporation CIEN shares gained 17% to $50.60 after the company reported better-than-expected Q4 sales results.
• Weibo Corporation WB jumped 16.4% to $18.02.
• GDS Holdings Limited GDS rose 15.3% to $20.27.
• iQIYI, Inc. IQ gained 14.8% to $3.64.
• Lufax Holding Ltd LU rose 14.8% to $2.2150.
• Kingsoft Cloud Holdings Limited KC rose 14.8% to $3.42.
• Niu Technologies NIU gained 14.8% to $5.29
• Tuniu Corporation TOUR rose 14.5% to $2.02 after gaining over 20% on Wednesday. Tuniu recently posted a Q3 loss of $0.03 per share.
• HUYA Inc. HUYA gained 14.1% to $2.9101.
• Qutoutiao Inc. QTT rose 13.2% to $0.6050 after dropping 11% on Wednesday.
• Pennsylvania Real Estate Investment Trust PEI gained 13.1% to $2.6018.
• Infinera Corporation INFN gained 12.6% to $7.20. Infinera, last month, reported better-than-expected Q3 EPS and sales results..
• Melco Resorts & Entertainment Limited MLCO rose 11.8% to $11.62.
• CarGurus, Inc. CARG gained 11.6% to $13.32. CarGurus reported a $250 million share repurchase program.
• Datadog, Inc. DDOG gained 9% to $74.35. Datadog Director Matthew Jacobson acquired a total of 192,154 shares an average price of $69.35.
• Bilibili Inc. BILI rose 9% to $23.67 after gaining over 5% on Wednesday.
• HashiCorp, Inc. HCP gained 8.3% to $28.94 after the company reported better-than-expected Q3 sales results. The company also issued Q4 and FY23 EPS and sales guidance above analyst estimates.
• Atlassian Corporation TEAM jumped 7.8% to $135.29.
• Tencent Music Entertainment Group TME gained 6.7% to $7.83. Morgan Stanley upgraded Tencent Music from Equal-Weight to Overweight and raised the price target from $4.5 to $8.5.

Losers

• Eiger BioPharmaceuticals, Inc. EIGR shares fell 71.6% to $1.0908 after the company announced topline primary Week 48 data from its Phase 3 D-LIVR study of lonafarnib in two regimens in patients with chronic Hepatitis Delta Virus (HDV).
• Relmada Therapeutics, Inc. RLMD fell 49.5% to $2.10 after the company said the RELIANCE trial for REL-1017 did not meet the primary endpoint.
• Design Therapeutics, Inc. DSGN fell 41.1% to $7.47 after the company reported data from its single-ascending dose trial of DT-216 for the treatment of Friedreich ataxia and portfolio progress.
• Context Therapeutics Inc. CNTX dropped 27.7% to $1.0050 after the company reported preliminary Phase 2 data for ONA-XR metastatic breast cancer.
• TransCode Therapeutics, Inc. RNAZ fell 19.4% to $0.7901. TransCode Therapeutics shares jumped 133% on Wednesday after the company announced withdrawal of the Registration Statement on Form S-1 filed on November 28, 2022 for a share offering for up to 12.5 million.
• Cano Health, Inc. CANO dropped 18% to $1.3957 following a report suggesting Third Point has sold its stake in the company.
• Instil Bio, Inc. TIL fell 18% to $1.00. Instil Bio announced plans to discontinue unmodified TIL programs including DELTA-1 and DELTA-2 trials of ITIL-168. The company will also reduce workforce by 60%.
• EBET, Inc. EBET dropped 15.4% to $0.4490.
• Connexa Sports Technologies Inc. CNXA declined 13% to $0.1717.
• Ambrx Biopharma Inc. AMAM dropped 12.5% to $0.41.
• Cosmos Holdings Inc. COSM shares fell 11.5% to $0.3990 after declining over 4% on Wednesday.
• Locafy Limited LCFY fell 11.1% to $5.59 after dropping over 14% on Wednesday.
• Chart Industries, Inc. GTLS dropped 10.8% to $120.29. Chart Industries reported proposed public offerings of $600 million of common stock and $300 million of depositary shares.
• HTG Molecular Diagnostics, Inc. HTGM dipped 10.1% to $0.2157.
• Mirati Therapeutics, Inc. MRTX fell 9.1% to $45.06. JP Morgan and BMO Capital downgraded the stock.
• 17 Education & Technology Group Inc. YQ shares fell 6.2% to $1.21. 17 Education & Technology posted a Q3 loss of $0.01 per share.

Also check this out Ethereum Moves Higher; Axie Infinity Becomes Top Loser.